Treatment should be discontinued if patients have not lost at least 5% of their initial body weight after 12 weeks on the full 3.0 mg dose
Ongoing phase 3 programs (such as the TRIUMPH and TRANSCEND series) continue to evaluate these outcomes in larger, longer-term settings, including direct comparisons with tirzepatide
Managing Your Health on a GLP-1 Program At TrimRx, we prioritize a holistic approach to health
These little pills can be a game-changer in your weight loss plan, especially when sticking with diet and exercise just aint cutting it
At the high end, switching from a 5 mg vial to a 60 mg vial can cut your per-milligram cost by more than half
The collaboration, the second between the companies, will entail Lilly applying Nimbus computational chemistry and structure-based drug design approach to an early-stage, small molecule discovery program designed to address what Nimbus said in a statement was a significant unmet need in obesity